Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Tobacco-specific nitrosamines in new tobacco products.

Stepanov I, Jensen J, Hatsukami D, Hecht SS.

Nicotine Tob Res. 2006 Apr;8(2):309-13.

PMID:
16766423
2.

Smoking topography, brand switching, and nicotine delivery: results from an in vivo study.

Hammond D, Fong GT, Cummings KM, Hyland A.

Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1370-5.

3.

Similar uptake of lung carcinogens by smokers of regular, light, and ultralight cigarettes.

Hecht SS, Murphy SE, Carmella SG, Li S, Jensen J, Le C, Joseph AM, Hatsukami DK.

Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):693-8. Erratum in: Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1568.

4.

Smokeless tobacco use and risk of cancer of the pancreas and other organs.

Boffetta P, Aagnes B, Weiderpass E, Andersen A.

Int J Cancer. 2005 May 10;114(6):992-5.

5.

Smokeless tobacco use: harm reduction or induction approach?

Hatsukami DK, Lemmonds C, Tomar SL.

Prev Med. 2004 Mar;38(3):309-17. Review.

PMID:
14766113
6.

Surveillance of smokeless tobacco nicotine, pH, moisture, and unprotonated nicotine content.

Richter P, Spierto FW.

Nicotine Tob Res. 2003 Dec;5(6):885-9.

PMID:
14668072
7.

Effect of smokeless tobacco (snus) on smoking and public health in Sweden.

Foulds J, Ramstrom L, Burke M, Fagerström K.

Tob Control. 2003 Dec;12(4):349-59. Review.

8.

Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine.

Carmella SG, Han S, Fristad A, Yang Y, Hecht SS.

Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1257-61.

9.

What smokers believe about light and ultralight cigarettes.

Etter JF, Kozlowski LT, Perneger TV.

Prev Med. 2003 Jan;36(1):92-8.

PMID:
12473429
10.

Bupropion for the treatment of nicotine dependence in spit tobacco users: a pilot study.

Dale LC, Ebbert JO, Schroeder DR, Croghan IT, Rasmussen DF, Trautman JA, Cox LS, Hurt RD.

Nicotine Tob Res. 2002 Aug;4(3):267-74.

PMID:
12215235
11.
12.

Smokers' beliefs about "Light" and "Ultra Light" cigarettes.

Shiffman S, Pillitteri JL, Burton SL, Rohay JM, Gitchell JG.

Tob Control. 2001;10 Suppl 1:i17-23.

13.

Oral spit tobacco: addiction, prevention and treatment.

Hatsukami DK, Severson HH.

Nicotine Tob Res. 1999 Mar;1(1):21-44. Review.

PMID:
11072386
14.

Modelling covariance structure in the analysis of repeated measures data.

Littell RC, Pendergast J, Natarajan R.

Stat Med. 2000 Jul 15;19(13):1793-819. Review.

PMID:
10861779
15.

An examination of cigarette brand switching to reduce health risks.

Haddock CK, Talcott GW, Klesges RC, Lando H.

Ann Behav Med. 1999 Spring;21(2):128-34.

PMID:
10499133
16.

Smoking behaviour and compensation: a review of the literature.

Scherer G.

Psychopharmacology (Berl). 1999 Jul;145(1):1-20. Review.

PMID:
10445368
17.

Smokeless tobacco cessation.

Severson HH, Hatsukami D.

Prim Care. 1999 Sep;26(3):529-51.

PMID:
10436286
18.

Determination of nicotine, pH, and moisture content of six U.S. commercial moist snuff products--Florida, January-February 1999.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 1999 May 21;48(19):398-401.

19.

Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation.

Hecht SS, Carmella SG, Chen M, Dor Koch JF, Miller AT, Murphy SE, Jensen JA, Zimmerman CL, Hatsukami DK.

Cancer Res. 1999 Feb 1;59(3):590-6.

20.

Errors in using tobacco withdrawal scale.

Hughes J, Hatsukami DK.

Tob Control. 1998 Spring;7(1):92-3. No abstract available.

Supplemental Content

Support Center